` CUBT (Curative Biotechnology Inc) vs S&P 500 Comparison - Alpha Spread

C
CUBT
vs
S&P 500

Over the past 12 months, CUBT has underperformed S&P 500, delivering a return of -14% compared to the S&P 500's +12% growth.

Stocks Performance
CUBT vs S&P 500

Loading
CUBT
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
CUBT vs S&P 500

Performance Gap Between CUBT and GSPC
HIDDEN
Show

Performance By Year
CUBT vs S&P 500

Loading
CUBT
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Curative Biotechnology Inc vs Peers

S&P 500
CUBT
AMGN
ARGX
ALNY
603259
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Curative Biotechnology Inc
Glance View

Market Cap
17.6m USD
Industry
N/A

Curative Biotechnology, Inc. engages in the provision of software solutions for the healthcare market. The company is headquartered in Boca Raton, Florida. The company went IPO on 2001-07-11. The firm is focused on identifying, acquiring and developing disease modifying therapeutic drug candidates with a concentration on rare disease indications. Curative Biotech has ongoing programs in three different therapeutic areas: infectious disease, neuro oncology and degenerative eye disease. The firm's pipeline includes IMT504, CURB906 and Metformin Reformulation. IMT504 is a immune therapy to treat rabies. CURB906 is a fully humanized CD56 monoclonal antibody carrying a cytotoxic drug conjugate directly to the tumor site to kill the tumor by inhibiting tumor growth and migration of the tumor. Metformin Reformulation to treat degenerative eye disease.

CUBT Intrinsic Value
Not Available
Back to Top